NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024Mary B. Daly, Susan Darlow, Heather H. Cheng et al.|Journal of the National Comprehensive Cancer Network|2023Cited by 284
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyNeil P. Shah, Kristina M. Gregory, Ravi Bhatia et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 116
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In OncologyRachel Hodan, Zeenat Diwan, Samir Gupta et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 91
CML and the WHO: Why?Ellin Berman, Brian Druker, Neil P. Shah et al.|Journal of Clinical Oncology|2023Cited by 14